AI-generated analysis. Always verify with the original filing.
Annovis Bio, Inc. disclosed that Mark Guerin is no longer employed as Chief Financial Officer effective March 23, 2026, with no disagreement on operations, policies, or practices. The board anticipates appointing Maria Maccecchini, the Chief Executive Officer, as Acting Chief Financial Officer until a replacement is identified.
Event Type
Disclosure
Mandatory
Variant
8-K
. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements Effective March 23, 2026, Mark G
Financial Statements and Exhibits Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant
Mark Guerin
Effective: 2026-03-23
did not arise from any disagreement with the Company or any matter relating to the Company’s operations, policies or practices
Maria Maccecchini
until a replacement can be identified